2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Sitosterolemia: new trials by email Literature Review of Sitosterolemia trials Research Report on Sitosterolemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia SCH-58235, Ezetimibe - Heart Diseases, Metabolism, Inborn Errors | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 3 | 2004-12-01 | 2008-03-04 |
| An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED) MK0653, ezetimibe, Comparator: placebo - Lipid Metabolism, Inborn Errors, Heart Disease | Phase 3 | Completed | Organon and Co | 30 | 2004-10-01 | 2024-08-15 |
Heart Diseases (2) · Atherosclerosis (1) · Lipid Metabolism, Inborn Errors (1) · Metabolism, Inborn Errors (1)
Cardiovascular Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Lipid Metabolism Disorders (1) · Metabolism, Inborn Errors (1) · Vascular Diseases (1)
Ezetimibe (2)
National Heart, Lung, and Blood Institute (NHLBI) (1) · Organon and Co (1)
United States (1)